Entering text into the input field will update the search result below

Cardium Therapeutics misses by $0.17, misses on revenues

Aug. 14, 2013 9:08 AM ETCardium Therapeutics, Inc (CXM-OLD) StockCXM-OLDBy: Gaurav Batavia, SA News Editor
  • Cardium Therapeutics (NYSEMKT:CXM): Q2 EPS of -$0.37 misses by $0.17.
  • Revenue of $0.584M misses by $0.42M. (PR)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CXM-OLD--
Cardium Therapeutics, Inc